prime medicine-Prime Medicine, Inc. (PRME) Reports Q1 Loss, Misses Revenue Estimates

Prime Medicine, Inc. (PRME) came out with a quarterly loss of $0.40 per share versus the Zacks Consensus Estimate of a loss of$ 0.32. This compares to loss of $0.44 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -25%. A quarter ago, it was expected that this company would post a loss of$ 0.37 per share when it actually produced a loss of $0.31, delivering a surprise of 16.22%.Over the last four quarters, the company has surpa ...